Florence, Italie

Florence, Italie
Messe Wien Exhibition Congress Center, Vienne, Autriche
RAI Amsterdam, Pays-Bas
WALTHAM, MA - May 1, 2023 (GLOBE NEWSWIRE) — BVI, a diversified global ophthalmic device company, today announced it has completed enrollment of its U.S. Investigational Device Exemption (IDE) clinical study for its latest hydrophobic trifocal intraocular lens, FINEVISION® HP. En savoir plus
WALTHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) — BVI, a diversified global ophthalmic device company, today announced certification for its intraocular lens (IOL) portfolio under the European Medical Device Regulation (MDR, (EU) 2017/745) from its Notified Body, the British Standards Institution (BSI)¹. The new regulatory criteria came into effect in May 2021, replacing the prior Medical Device Directive (MDD). En savoir plus
Government customers can now purchase BVI’s high-quality ophthalmic products through Lovell Government Services’ ECAT Contract. En savoir plus
Supports surgeon-centered digital visualization, improved ergonomics and real-timeguidance to surgical decision-making process En savoir plus
BVI transformed from producing surgical knives to treating eye diseases as a next-generation company. Here’s how the business is still innovating. En savoir plus